Cargando…

Molecular Analysis and Modeling of Hepatitis E Virus Helicase and Identification of Novel Inhibitors by Virtual Screening

The hepatitis E virus- (HEV-) helicase as a novel drug-target was evaluated. While cell culture model was used for mutational characterization of helicase, in silico protein modeling and virtual screening were employed to identify helicase inhibitors. None of the saturation mutant replicons signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parvez, Mohammad K., Subbarao, Naidu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136533/ https://www.ncbi.nlm.nih.gov/pubmed/30246023 http://dx.doi.org/10.1155/2018/5753804

Ejemplares similares

Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica
por: Nagpal, Isha, et al.
Publicado: (2012)

Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
por: Kumari, Madhulata, et al.
Publicado: (2021)

Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
por: Furuta, Atsushi, et al.
Publicado: (2015)

High Throughput Virtual Screening to Identify Novel natural product Inhibitors for MethionyltRNA-Synthetase of Brucella melitensis
por: Kumari, Madhulata, et al.
Publicado: (2017)

Inhibition of Hepatitis E Virus Replication by Novel Inhibitor Targeting Methyltransferase
por: Hooda, Preeti, et al.
Publicado: (2022)

Identification of Novel Small Molecules as Inhibitors of Hepatitis C Virus by Structure-Based Virtual Screening
por: Li, Jing, et al.
Publicado: (2013)

Designing novel inhibitors against Mycobacterium tuberculosis FadA5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds
por: Jaiswal, Atul Kumar, et al.
Publicado: (2018)

Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease
por: Parvez, Mohammad Khalid, et al.
Publicado: (2014)

Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme
por: Adon, Tenzin, et al.
Publicado: (2023)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
por: Almeleebia, Tahani M., et al.
Publicado: (2022)

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease
por: Khan, Mohd. Babu, et al.
Publicado: (2018)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Zhang, Yi, et al.
Publicado: (2020)

Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors
por: ŞAHİN, Kader, et al.
Publicado: (2020)

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
por: Kumari, Madhulata, et al.
Publicado: (2016)

Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays
por: Mukherjee, Sourav, et al.
Publicado: (2012)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study
por: Parvez, Mohammad K., et al.
Publicado: (2019)

Identification and Biochemical Characterization of Halisulfate 3 and Suvanine as Novel Inhibitors of Hepatitis C Virus NS3 Helicase from a Marine Sponge
por: Furuta, Atsushi, et al.
Publicado: (2014)

Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening
por: Halim, Sobia A., et al.
Publicado: (2017)

Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors
por: El Hassab, Mahmoud A., et al.
Publicado: (2022)

Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity
por: Parvez, Mohammad Khalid
Publicado: (2013)

Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches
por: Imran, Muhammad, et al.
Publicado: (2020)

Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening
por: Volynets, Galyna P., et al.
Publicado: (2022)

Identification of potent HDAC 2 inhibitors using E-pharmacophore modelling, structure-based virtual screening and molecular dynamic simulation
por: Pai, Padmini, et al.
Publicado: (2022)

Multiple virtual screening approaches for finding new Hepatitis c virus RNA-dependent RNA polymerase inhibitors: Structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors
por: ElHefnawi, Mahmoud, et al.
Publicado: (2012)

Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer
por: Pathak, Rajesh Kumar, et al.
Publicado: (2014)

Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2019)

DNA-conjugated gold nanoparticles based colorimetric assay to assess helicase activity: a novel route to screen potential helicase inhibitors
por: Deka, Jashmini, et al.
Publicado: (2017)

Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations
por: Park, Hwangseo, et al.
Publicado: (2013)

Identification of Plant Peptides as Novel Inhibitors of Orthohepevirus A (HEV) Capsid Protein by Virtual Screening
por: Mustafa, Ghulam, et al.
Publicado: (2023)

Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors
por: Valasani, Koteswara Rao, et al.
Publicado: (2014)

Identification of probable inhibitors for the DNA polymerase of the Monkeypox virus through the virtual screening approach
por: Kumari, Swati, et al.
Publicado: (2023)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors
por: Botelho, Fernanda D., et al.
Publicado: (2020)

Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening
por: Gimeno, Aleix, et al.
Publicado: (2021)

Molecular Docking and Virtual Screening of an Influenza Virus Inhibitor That Disrupts Protein–Protein Interactions
por: Ren, Yixin, et al.
Publicado: (2021)

Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors
por: Fei, Jia, et al.
Publicado: (2013)

In silico identification of novel PKC βII inhibitors: ligand and receptor based pharmacophore modeling, virtual screening, and molecular dynamics study
por: Grewal, Baljinder K, et al.
Publicado: (2012)

Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening
por: Velnati, Suresh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u124e1innrt9qf2kh5ol8npsvo